-
MEDIA RELEASE | Menzies researchers in the top 2 per cent
Menzies School of Health Research is celebrating the work of its researchers who have been ranked amongst the world’s top scientists.
-
Researchers at CDU some of the most influential in their fields
According to a Stanford University study, there were 22 academics from CDU and Menzies School of Health research who ranked in the top two per cent of researchers referenced in their respected disciplines for 2020.
-
$74 million investment in Australian-led clinical trials
Includes a clinical trial in PNG led by Dr Holger Unger and a trial by Prof Peter Morris to reduce infection in Aboriginal mothers and babies.
-
Preventing infant wheeze and childhood asthma
A new $1.6 million Australian-UK world-first project aimed at preventing wheeze in preschool children and potentially asthma in later childhood by using an orally administered bacteria lysate to boost immune systems has been announced.
-
Ear disease in Aboriginal and Torres Strait Islander children
In remote communities across the Northern Territory (NT), only one in 10 Aboriginal children younger than three years have healthy ears, a new report in the Medical Journal of Australia (MJA) has found.
-
Otitis media guidelines for Australian Aboriginal and Torres Strait Islander children
This 2020 update by the Centre of Research Excellence in Ear and Hearing Health of Aboriginal and Torres Strait Islander Children.
-
CDU academics named among world’s most influential
Menzies School of Health Research Professor Bart Currie, Professor Anne Chang AM, Professor Ric Price, Associate Professor Steven Tong, Professor Nicholas Anstey, Professor Joshua Davis, Professor Alan Cass, Professor Peter Morris and Professor Amanda Leach
-
Acute lower respiratory infections in Indigenous infants in the NT
Menzies senior research fellow Dr Michael Binks examined acute lower respiratory infection (ALRI) hospital admissions among Indigenous infants in the Northern Territory from 2006 to 2015, across three periods of different pneumococcal conjugate vaccine (PCV) use.
-
Northern Territory paediatrician honoured with Menzies Medallion
Long-term Northern Territory paediatrician, Professor Peter Morris has been awarded the prestigious Menzies Medallion.
-
Australian Doctor - otitis media clinical trial
Otitis Media - a clinical trial where Indigenous infants will receive an extra dose of pneumococcal vaccine to try and cut down the rates of incidence.
-
New Vaccine could help reduce Chronic ear disease.
Menzies School of Health researchers are hoping to reduce rates of a chronic ear disease called Otis Media, in remote indigenous communities. (Image source: creative commons)
-
Extra vaccines may reduce 'unacceptable rates' of chronic ear disease in Indigenous children
The Menzies School of Health Research is conducting a clinical trial in remote communities in the Northern Territory and Western Australia, and hope the results will change the public health approach and give more help to families.
-
New treatment trialled in battle against ear disease
In a world first, Northern Territory researchers are trialling a new treatment to heal an ear disease plaguing Indigenous communities and causing lifelong disadvantage.
-
Rapid iron infusion trial to tackle widespread deficiency among children in Australia’s Northern Territory
Foodnavigator-asia.com: A project in Australia’s Northern Territory is to trial giving anaemic children rapid iron infusions before they are discharged from hospital in an attempt to reduce the risk of ongoing iron deficiency.
-
Menzies secures 2016 NHMRC funding for groundbreaking projects
Innovation and transformation are at the heart of the Menzies School of Health Research (Menzies) projects which have secured funding in the highly competitive NHMRC grant round.
